We are live on ! Find out more
AAM

Auxier Asset Management Portfolio holdings

AUM $696M
1-Year Est. Return 18.07%
This Fund
S&P 500
This Quarter Est. Return
+15.48%
1 Year Est. Return
+18.07%
3 Year Est. Return
+58.42%
5 Year Est. Return
+82.9%
10 Year Est. Return
+252.62%
AUM
$453M
AUM Growth
+$52.8M
Cap. Flow
-$2.57M
Cap. Flow %
-0.57%
Top 10 Hldgs %
34.67%
Holding
155
New
5
Increased
18
Reduced
80
Closed
8

Top Buys

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$1.9M
2
ABBV icon
AbbVie
ABBV
+$630K
3
BMY icon
Bristol-Myers Squibb
BMY
+$549K
4
FORR icon
Forrester Research
FORR
+$444K
5
PFE icon
Pfizer
PFE
+$408K

Top Sells

Rank Stock Value
1
RTN
Raytheon Company
RTN
+$1.64M
2
AGN
Allergan plc
AGN
+$1.48M
3
BIIB icon
Biogen
BIIB
+$586K
4
ABT icon
Abbott
ABT
+$502K
5
MSFT icon
Microsoft
MSFT
+$441K

Sector Composition

Rank Sector Weight
1 Healthcare 28.41%
2 Consumer Staples 17.95%
3 Financials 17.53%
4 Technology 10.41%
5 Consumer Discretionary 6.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
1
UnitedHealth
UNH
$387B
$26M 5.73%
88,129
MSFT icon
2
Microsoft
MSFT
$2.93T
$25.6M 5.64%
125,650
-2,430
-2% -$441K
MA icon
3
Mastercard
MA
$480B
$15.8M 3.49%
53,575
-15
-0% -$4.23K
PM icon
4
Philip Morris
PM
$301B
$14.4M 3.18%
205,831
-905
-0.4% -$66K
PEP icon
5
PepsiCo
PEP
$187B
$14M 3.1%
106,148
-2,050
-2% -$270K
MDT icon
6
Medtronic
MDT
$106B
$13.2M 2.91%
144,080
-225
-0.2% -$21.6K
KR icon
7
Kroger
KR
$36B
$12.8M 2.83%
378,651
+140
+0% +$4.54K
ELV icon
8
Elevance Health
ELV
$80.9B
$12.8M 2.82%
48,549
+495
+1% +$132K
JNJ icon
9
Johnson & Johnson
JNJ
$609B
$12.7M 2.81%
90,460
-2,640
-3% -$385K
MRK icon
10
Merck
MRK
$315B
$9.77M 2.15%
132,374
-1,284
-1% -$96.7K
BNY
11
Bank of New York Mellon
BNY
$108B
$9.3M 2.05%
240,579
-2,030
-0.8% -$74.3K
V icon
12
Visa
V
$682B
$8.35M 1.84%
43,228
ZBH icon
13
Zimmer Biomet
ZBH
$17.6B
$8.35M 1.84%
72,058
-82
-0.1% -$9.45K
BAC icon
14
Bank of America
BAC
$430B
$8.07M 1.78%
339,972
-460
-0.1% -$10.9K
ABT icon
15
Abbott
ABT
$175B
$8.04M 1.77%
87,945
-5,552
-6% -$502K
TRV icon
16
Travelers Companies
TRV
$78.5B
$6.97M 1.54%
61,088
-61
-0.1% -$6.43K
HD icon
17
Home Depot
HD
$338B
$6.65M 1.47%
26,556
-1,000
-4% -$229K
BIIB icon
18
Biogen
BIIB
$30.4B
$6.5M 1.44%
24,312
-1,950
-7% -$586K
WMT icon
19
Walmart Inc
WMT
$909B
$6.43M 1.42%
161,076
+1,290
+0.8% +$53.1K
MO icon
20
Altria Group
MO
$124B
$6.08M 1.34%
154,999
-1,215
-0.8% -$47.4K
CVS icon
21
CVS Health
CVS
$137B
$6.04M 1.33%
92,912
+4,560
+5% +$287K
CERN
22
DELISTED
Cerner Corp
CERN
$5.64M 1.24%
82,240
-2,425
-3% -$167K
GOOGL icon
23
Alphabet (Google) Class A
GOOGL
$4.23T
$5.46M 1.21%
77,080
-260
-0.3% -$17.5K
KO icon
24
Coca-Cola
KO
$351B
$5.42M 1.2%
121,253
-200
-0.2% -$9.21K
UN
25
DELISTED
Unilever NV New York Registry Shares
UN
$4.94M 1.09%
92,813
-1,130
-1% -$57.4K

Similar funds

Auxier Asset Management's Q2 2020 Portfolio in Review

As of Q2 2020, Auxier Asset Management held 155 positions worth $453M, up 13% from $401M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Auxier Asset Management's Q2 2020 filing shows 5 new, 18 increased, 80 reduced and 8 closed positions. Its largest new stake was RTX Corp: 30,516 shares worth $1.88M. The largest sale was Raytheon Company, an estimated $1.64M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 29% a quarter earlier, followed by Consumer Staples and Financials.

  • Auxier Asset Management's largest Q2 2020 buy was RTX Corp: 30,516 shares worth $1.88M.
  • Auxier Asset Management added most to AbbVie in Q2 2020, an estimated $630K increase.
  • Auxier Asset Management's biggest Q2 2020 reduction was Biogen, cutting an estimated $586K.
  • Auxier Asset Management fully exited Raytheon Company in Q2 2020, selling an estimated $1.64M.
  • Auxier Asset Management's ten largest holdings make up 35% of its $453M portfolio in Q2 2020.
  • Auxier Asset Management opened 5 new positions and closed 8 in Q2 2020.
  • Auxier Asset Management's portfolio value rose 13% quarter-over-quarter to $453M.

Based on Auxier Asset Management's 13F filing for Q2 2020, filed 20 Aug 2020.